E
ADMA icon

Ergoteles’s ADMA Biologics ADMA Stock Holding History

Ergoteles’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-19,462
Closed -$71.8K – 38
2023
Q2 		$71.8K Buy
+19,462
New +$72.1K ﹤0.01% 934
2022
Q2 		– Sell
-71,400
Closed -$131K – 1601
2022
Q1 		$131K Buy
+71,400
New +$111K 0.01% 1077
2021
Q3 		– Sell
-299,500
Closed -$479K – 1150
2021
Q2 		$479K Buy
+299,500
New +$527K 0.01% 826
2021
Q1 		– Sell
-30,100
Closed -$59K – 768
2020
Q4 		$59K Buy
+30,100
New +$63.3K ﹤0.01% 638

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return